Switch to low bandwidth version Close

Cancer Research UK Cancer Survival Group

LSHTM logoCancer Research UK logo

Our research is designed to describe and explain local, national, international and socio-economic differences and inequalities in cancer survival. The results help policymakers to target investment in cancer services to improve survival and reduce inequalities. We also invest in methodological innovation in survival analysis. We have shown that socio-economic inequalities in survival in England were increasing up to 2001, a finding that has had important policy implications. The EUROCARE-3 study has indicated lower survival in the United Kingdom than in some other European populations, although the differences are becoming less marked for some cancers. Geographic differences in survival are being explored within the UK and, in the EUROCARE and CONCORD projects, in collaboration with cancer registries and research institutions in over seventy countries worldwide.

We have run an annual short course on cancer survival since 2006. Details of our short course for 2015, Cancer Survival: Principles, Methods and Applications, are now available. The benefits of attending the course, and the importance of sponsorship, have been publicised by the International Atomic Energy Agency's Programme of Action for Cancer Therapy (PACT). Participants based in low-, lower-middle and upper-middle income countries are entitled to a special discounted fee.The 

Cancer Survival Group is now on Twitter – see our news page.

For further details of our research publications, see the list of publications of the Cancer Survival Group.

We collaborate closely with the Office for National Statistics (ONS) on a range of projects, analysing and publishing trends and socio-demographic patterns in cancer survival for all the major cancers by age, sex and socio-economic status in England. We are examining cancer incidence, mortality and survival trends among South Asians, the largest ethnic minority in the United Kingdom.

With the Childhood Cancer Research Group and the UK Clinical Trials Service Unit in Oxford, we have shown that childhood leukaemia incidence increased over much of the 20th century, and survival rose steadily since the 1960s. We have also begun international collaborations to develop the methodology for cancer survival analysis. Statistical software and other tools for cancer survival analysis have been made freely accessible via these web pages.

An example of our recent research is Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. This paper, published online by The Lancet on 22 December 2010, is available as a word-processed version, or the full open access paper can be found on The Lancet website at: www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62231-3/abstract.

Back to top